GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: Spectinamide 1599 is an analogue of spectinomycin, being developed to treat multi-drug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) [1].
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Bruhn DF, Scherman MS, Liu J, Scherbakov D, Meibohm B, Böttger EC, Lenaerts AJ, Lee RE. (2015)
In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics. Sci Rep, 5: 13985. [PMID:26365087] |